__timestamp | Grifols, S.A. | Travere Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 3355384000 | 28203205 |
Thursday, January 1, 2015 | 3934563000 | 99892000 |
Friday, January 1, 2016 | 4049830000 | 133591000 |
Sunday, January 1, 2017 | 4318073000 | 154937000 |
Monday, January 1, 2018 | 4486724000 | 164246000 |
Tuesday, January 1, 2019 | 5098691000 | 175338000 |
Wednesday, January 1, 2020 | 5340038000 | 198321000 |
Friday, January 1, 2021 | 4933118000 | 227490000 |
Saturday, January 1, 2022 | 6063967000 | 212018000 |
Sunday, January 1, 2023 | 6591977000 | 145238000 |
Unlocking the unknown
In the competitive landscape of the pharmaceutical industry, Grifols, S.A. and Travere Therapeutics, Inc. have been vying for dominance in yearly revenue. Since 2014, Grifols has consistently outperformed Travere, showcasing a robust growth trajectory. By 2023, Grifols' revenue surged by approximately 97% from its 2014 figures, reaching a peak of over $6.6 billion. In contrast, Travere's revenue, while growing, remains modest, peaking at around $227 million in 2021 before a slight decline. This stark contrast highlights Grifols' strategic market positioning and operational efficiency. The data underscores Grifols' dominance, with its revenue being nearly 30 times that of Travere's in 2023. As the industry evolves, these figures provide a compelling narrative of growth, strategy, and market leadership.
Pfizer Inc. and Grifols, S.A.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Gilead Sciences, Inc. vs Grifols, S.A.
Revenue Showdown: Teva Pharmaceutical Industries Limited vs Grifols, S.A.
Biogen Inc. vs Grifols, S.A.: Annual Revenue Growth Compared
Biogen Inc. vs Travere Therapeutics, Inc.: Examining Key Revenue Metrics
Incyte Corporation or Grifols, S.A.: Who Leads in Yearly Revenue?
Revenue Insights: Grifols, S.A. and Alkermes plc Performance Compared
Breaking Down Revenue Trends: Grifols, S.A. vs ACADIA Pharmaceuticals Inc.
Who Generates More Revenue? Grifols, S.A. or MorphoSys AG
Grifols, S.A. vs ImmunityBio, Inc.: Annual Revenue Growth Compared
Revenue Insights: Grifols, S.A. and Ligand Pharmaceuticals Incorporated Performance Compared
Ligand Pharmaceuticals Incorporated or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?